Topics

Latest

AI

Amazon

Article image

Image Credits:Tom Werner / Getty Images

Apps

Biotech & Health

Climate

Two doctors sitting at a large computer desk talking about a patient’s CT scans displayed on the monitors.

Image Credits:Tom Werner / Getty Images

Cloud Computing

Commerce Department

Crypto

Quibim: QP-Insights

QP-InsightsImage Credits:Quibim

enterprisingness

EVs

Fintech

fund-raise

Gadgets

Gaming

Google

Government & Policy

computer hardware

Instagram

Layoffs

Media & Entertainment

Meta

Microsoft

Privacy

Robotics

security measure

Social

infinite

Startups

TikTok

deportation

Venture

More from TechCrunch

outcome

Startup Battlefield

StrictlyVC

Podcasts

video recording

Partner Content

TechCrunch Brand Studio

Crunchboard

Contact Us

Quibim , a Spanish startup that ’s evolve foundational AI models for medical imaging span oncology , immunology , clinical neurology , and metabolic upset , hasraised $ 50 millionin a Series A round of funding .

The hard cash injection come asAI makes ever deeper inroadsinto healthcare , sweep everything fromdrug discoverytoclinical trials .

Quibim , for its part , is correct out to heighten symptomatic accuracy and disease spotting from visual information procured from X - rays , CT scans , and MRIs . The company ’s flagship merchandise , QP - Prostate , is designed to ameliorate prostate cancer detection , with disjoined product in the whole kit and boodle for thebrain , liver , breast , andlung .

Separately , Quibim also offersQP - Insightsfor processing multi - omics data ( i.e. dissimilar types of biological data ) , for representative in clinical trials and related studies .

Quibim says its longer - terminal figure plan is to createdigital twinsof the intact human eubstance , serving “ dynamic manikin ” that help oneself the aesculapian residential area better understand the human body . That all begins at the “ organ and wound level , ” as demonstrated by QP - Prostate .

Plans to grow in the U.S.

Valencia - based Quibim has now put forward around $ 70 million since its origin , and with its latest funding , the company says it plans to double - down on its U.S. expansion architectural plan . Indeed , Quibimreceived FDA 510(k ) clearanceback in 2023 to market its QP - Prostate product ; it alsohired its firstchief aesculapian officer in the U.S.

At the time of writing , Quibim say it has 170 installations globally , with partners including Stanford University and Harvard - affiliated integrated healthcare systemMass General Brigham . severally , Philipspreviously announced plansto integrate Quibim ’s AI models into its scanner .

Join us at TechCrunch Sessions: AI

Exhibit at TechCrunch Sessions: AI

Quibim ’s Series A round was take bySpanish venture upper-case letter house Asabysand individual fairness firmBuenavista , with involvement from a slew of institutional and single investor , including : Amadeus Capital Partners , Apex Ventures , Partech , and iPod and iPhone co - creatorTony Fadell .

“ Quibim ’s delegation is to change by reversal fancy into a accelerator for preciseness wellness , ” Quibim CEO and carbon monoxide gas - founderÁngel Alberich - Bayarrisaid in a statement . “ Our global expansion into the U.S. is a critical milepost as we work with pharmaceutical loss leader and health care provider to unlock the power of project to revolutionize diagnostics and amend patient outcomes . ”